KNOPP BIOSCIENCES ANNOUNCES RENEWAL OF NIH BLUEPRINT GRANT AWARD FOR ADVANCING KCNQ2 MODULATORS IN EPILEPSY
PITTSBURGH, PA, USA, OCTOBER 23, 2017—Knopp Biosciences LLC today announced the renewal and expansion of its grant award from the National Institutes of Health Blueprint Neurotherapeutics Network to advance novel treatments for epilepsy. The Phase 2 award under the … Continued